Cycad toxins, Helicobacter pylori and parkinsonism: cholesterol glucosides as the common denomenator.
Identifieur interne : 000620 ( Ncbi/Merge ); précédent : 000619; suivant : 000621Cycad toxins, Helicobacter pylori and parkinsonism: cholesterol glucosides as the common denomenator.
Auteurs : J D Schulz [Canada] ; E L Hawkes ; C A ShawSource :
- Medical hypotheses [ 0306-9877 ] ; 2006.
English descriptors
- KwdEn :
- Amyotrophic Lateral Sclerosis (chemically induced), Amyotrophic Lateral Sclerosis (metabolism), Cholesterol (analogs & derivatives), Cholesterol (metabolism), Cycas (adverse effects), Helicobacter Infections (metabolism), Helicobacter pylori (metabolism), Humans, Models, Biological, Parkinson Disease (metabolism), Parkinson Disease (microbiology), Plants, Toxic (adverse effects).
- MESH :
- chemical , analogs & derivatives : Cholesterol.
- adverse effects : Cycas, Plants, Toxic.
- chemically induced : Amyotrophic Lateral Sclerosis.
- metabolism : Amyotrophic Lateral Sclerosis, Cholesterol, Helicobacter Infections, Helicobacter pylori, Parkinson Disease.
- microbiology : Parkinson Disease.
- Humans, Models, Biological.
Abstract
Understanding sporadic cases of age-dependent neurodegenerative diseases such as parkinsonism requires the evaluation of potential environmental factors. Amyotrophic lateral sclerosis-parkinsonism dementia complex (ALS-PDC), a neurological disorder in which features of parkinsonism are present and for which no consistent genetic explanation has been found, has been linked to the consumption of cycad (Cycas micronesica). Similarly, epidemiological evidence suggests an association between parkinsonism and gastric ulcer caused by Helicobacter pylori infection. While common immunological and inflammatory changes have been proposed to account for the link between parkinsonism and H. pylori infection, we propose an alternate explanation based on our work on the "cycad theory" of ALS-PDC. Recent experiments in our laboratory have identified several sterol glucosides in cycad that have neurotoxic properties in vitro and that appear to be linked to the development of neurodegenerative disease in vivo. Specifically, mice fed cycad display behavioural symptoms of parkinsonism such as reduced gait length, as well as neuropathological signs such as a loss of striatal dopaminergic (DAergic) terminals and an upregulation of the dopamine D2 receptor. These cycad-derived sterol glucosides are structurally similar to cholesterol glucosides that account for a significant part pf the lipid profile of H. pylori. We hypothesize that cholesterol glucosides arising from H. pylori infection may act as neurotoxins, promoting the degeneration of the DAergic neurons affected in parkinsonism, in a similar reaction to that which is thought to link cycad consumption and ALS-PDC. This hypothesis will be tested in future studies that will include exposing mice to purified sterol or cholestorol glucosides derived from cycad and comparing these mice behaviourally and neuropathologically to ones chronically infected with H. pylori.
DOI: 10.1016/j.mehy.2004.12.033
PubMed: 16488551
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001210
- to stream PubMed, to step Curation: 001210
- to stream PubMed, to step Checkpoint: 001210
Links to Exploration step
pubmed:16488551Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cycad toxins, Helicobacter pylori and parkinsonism: cholesterol glucosides as the common denomenator.</title>
<author><name sortKey="Schulz, J D" sort="Schulz, J D" uniqKey="Schulz J" first="J D" last="Schulz">J D Schulz</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Ophthalmology, University of British Columbia, Vancouver, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Ophthalmology, University of British Columbia, Vancouver</wicri:regionArea>
<wicri:noRegion>Vancouver</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hawkes, E L" sort="Hawkes, E L" uniqKey="Hawkes E" first="E L" last="Hawkes">E L Hawkes</name>
</author>
<author><name sortKey="Shaw, C A" sort="Shaw, C A" uniqKey="Shaw C" first="C A" last="Shaw">C A Shaw</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2006">2006</date>
<idno type="RBID">pubmed:16488551</idno>
<idno type="pmid">16488551</idno>
<idno type="doi">10.1016/j.mehy.2004.12.033</idno>
<idno type="wicri:Area/PubMed/Corpus">001210</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001210</idno>
<idno type="wicri:Area/PubMed/Curation">001210</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001210</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001210</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001210</idno>
<idno type="wicri:Area/Ncbi/Merge">000620</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Cycad toxins, Helicobacter pylori and parkinsonism: cholesterol glucosides as the common denomenator.</title>
<author><name sortKey="Schulz, J D" sort="Schulz, J D" uniqKey="Schulz J" first="J D" last="Schulz">J D Schulz</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Ophthalmology, University of British Columbia, Vancouver, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Ophthalmology, University of British Columbia, Vancouver</wicri:regionArea>
<wicri:noRegion>Vancouver</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hawkes, E L" sort="Hawkes, E L" uniqKey="Hawkes E" first="E L" last="Hawkes">E L Hawkes</name>
</author>
<author><name sortKey="Shaw, C A" sort="Shaw, C A" uniqKey="Shaw C" first="C A" last="Shaw">C A Shaw</name>
</author>
</analytic>
<series><title level="j">Medical hypotheses</title>
<idno type="ISSN">0306-9877</idno>
<imprint><date when="2006" type="published">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Amyotrophic Lateral Sclerosis (chemically induced)</term>
<term>Amyotrophic Lateral Sclerosis (metabolism)</term>
<term>Cholesterol (analogs & derivatives)</term>
<term>Cholesterol (metabolism)</term>
<term>Cycas (adverse effects)</term>
<term>Helicobacter Infections (metabolism)</term>
<term>Helicobacter pylori (metabolism)</term>
<term>Humans</term>
<term>Models, Biological</term>
<term>Parkinson Disease (metabolism)</term>
<term>Parkinson Disease (microbiology)</term>
<term>Plants, Toxic (adverse effects)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Cholesterol</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Cycas</term>
<term>Plants, Toxic</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Amyotrophic Lateral Sclerosis</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Amyotrophic Lateral Sclerosis</term>
<term>Cholesterol</term>
<term>Helicobacter Infections</term>
<term>Helicobacter pylori</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiology" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Models, Biological</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Understanding sporadic cases of age-dependent neurodegenerative diseases such as parkinsonism requires the evaluation of potential environmental factors. Amyotrophic lateral sclerosis-parkinsonism dementia complex (ALS-PDC), a neurological disorder in which features of parkinsonism are present and for which no consistent genetic explanation has been found, has been linked to the consumption of cycad (Cycas micronesica). Similarly, epidemiological evidence suggests an association between parkinsonism and gastric ulcer caused by Helicobacter pylori infection. While common immunological and inflammatory changes have been proposed to account for the link between parkinsonism and H. pylori infection, we propose an alternate explanation based on our work on the "cycad theory" of ALS-PDC. Recent experiments in our laboratory have identified several sterol glucosides in cycad that have neurotoxic properties in vitro and that appear to be linked to the development of neurodegenerative disease in vivo. Specifically, mice fed cycad display behavioural symptoms of parkinsonism such as reduced gait length, as well as neuropathological signs such as a loss of striatal dopaminergic (DAergic) terminals and an upregulation of the dopamine D2 receptor. These cycad-derived sterol glucosides are structurally similar to cholesterol glucosides that account for a significant part pf the lipid profile of H. pylori. We hypothesize that cholesterol glucosides arising from H. pylori infection may act as neurotoxins, promoting the degeneration of the DAergic neurons affected in parkinsonism, in a similar reaction to that which is thought to link cycad consumption and ALS-PDC. This hypothesis will be tested in future studies that will include exposing mice to purified sterol or cholestorol glucosides derived from cycad and comparing these mice behaviourally and neuropathologically to ones chronically infected with H. pylori.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16488551</PMID>
<DateCreated><Year>2006</Year>
<Month>03</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted><Year>2006</Year>
<Month>06</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0306-9877</ISSN>
<JournalIssue CitedMedium="Print"><Volume>66</Volume>
<Issue>6</Issue>
<PubDate><Year>2006</Year>
</PubDate>
</JournalIssue>
<Title>Medical hypotheses</Title>
<ISOAbbreviation>Med. Hypotheses</ISOAbbreviation>
</Journal>
<ArticleTitle>Cycad toxins, Helicobacter pylori and parkinsonism: cholesterol glucosides as the common denomenator.</ArticleTitle>
<Pagination><MedlinePgn>1222-6</MedlinePgn>
</Pagination>
<Abstract><AbstractText>Understanding sporadic cases of age-dependent neurodegenerative diseases such as parkinsonism requires the evaluation of potential environmental factors. Amyotrophic lateral sclerosis-parkinsonism dementia complex (ALS-PDC), a neurological disorder in which features of parkinsonism are present and for which no consistent genetic explanation has been found, has been linked to the consumption of cycad (Cycas micronesica). Similarly, epidemiological evidence suggests an association between parkinsonism and gastric ulcer caused by Helicobacter pylori infection. While common immunological and inflammatory changes have been proposed to account for the link between parkinsonism and H. pylori infection, we propose an alternate explanation based on our work on the "cycad theory" of ALS-PDC. Recent experiments in our laboratory have identified several sterol glucosides in cycad that have neurotoxic properties in vitro and that appear to be linked to the development of neurodegenerative disease in vivo. Specifically, mice fed cycad display behavioural symptoms of parkinsonism such as reduced gait length, as well as neuropathological signs such as a loss of striatal dopaminergic (DAergic) terminals and an upregulation of the dopamine D2 receptor. These cycad-derived sterol glucosides are structurally similar to cholesterol glucosides that account for a significant part pf the lipid profile of H. pylori. We hypothesize that cholesterol glucosides arising from H. pylori infection may act as neurotoxins, promoting the degeneration of the DAergic neurons affected in parkinsonism, in a similar reaction to that which is thought to link cycad consumption and ALS-PDC. This hypothesis will be tested in future studies that will include exposing mice to purified sterol or cholestorol glucosides derived from cycad and comparing these mice behaviourally and neuropathologically to ones chronically infected with H. pylori.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schulz</LastName>
<ForeName>J D</ForeName>
<Initials>JD</Initials>
<AffiliationInfo><Affiliation>Department of Ophthalmology, University of British Columbia, Vancouver, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hawkes</LastName>
<ForeName>E L</ForeName>
<Initials>EL</Initials>
</Author>
<Author ValidYN="Y"><LastName>Shaw</LastName>
<ForeName>C A</ForeName>
<Initials>CA</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2006</Year>
<Month>02</Month>
<Day>20</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Med Hypotheses</MedlineTA>
<NlmUniqueID>7505668</NlmUniqueID>
<ISSNLinking>0306-9877</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>26671-80-7</RegistryNumber>
<NameOfSubstance UI="C027578">cholesteryl glucoside</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>97C5T2UQ7J</RegistryNumber>
<NameOfSubstance UI="D002784">Cholesterol</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName>
<QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002784" MajorTopicYN="N">Cholesterol</DescriptorName>
<QualifierName UI="Q000031" MajorTopicYN="Y">analogs & derivatives</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D029784" MajorTopicYN="N">Cycas</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016481" MajorTopicYN="N">Helicobacter Infections</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016480" MajorTopicYN="N">Helicobacter pylori</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008954" MajorTopicYN="Y">Models, Biological</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
<QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010947" MajorTopicYN="N">Plants, Toxic</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2004</Year>
<Month>10</Month>
<Day>14</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2004</Year>
<Month>12</Month>
<Day>16</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2006</Year>
<Month>2</Month>
<Day>21</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2006</Year>
<Month>6</Month>
<Day>30</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2006</Year>
<Month>2</Month>
<Day>21</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">16488551</ArticleId>
<ArticleId IdType="pii">S0306-9877(05)00292-6</ArticleId>
<ArticleId IdType="doi">10.1016/j.mehy.2004.12.033</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Canada</li>
</country>
</list>
<tree><noCountry><name sortKey="Hawkes, E L" sort="Hawkes, E L" uniqKey="Hawkes E" first="E L" last="Hawkes">E L Hawkes</name>
<name sortKey="Shaw, C A" sort="Shaw, C A" uniqKey="Shaw C" first="C A" last="Shaw">C A Shaw</name>
</noCountry>
<country name="Canada"><noRegion><name sortKey="Schulz, J D" sort="Schulz, J D" uniqKey="Schulz J" first="J D" last="Schulz">J D Schulz</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000620 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000620 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Canada |area= ParkinsonCanadaV1 |flux= Ncbi |étape= Merge |type= RBID |clé= pubmed:16488551 |texte= Cycad toxins, Helicobacter pylori and parkinsonism: cholesterol glucosides as the common denomenator. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:16488551" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \ | NlmPubMed2Wicri -a ParkinsonCanadaV1
This area was generated with Dilib version V0.6.29. |